Cargando…
Identification of Prognostic Markers in Argentinian Acute Lymphoblastic Leukemia Pediatric Patients Through Transcriptome Analysis: Differential Gene Expression, Mutational Status and Immune Microenvironment
Acute lymphoblastic leukemia (ALL) is the most incident pediatric cancer. Although considerable progress has been made on treatment efficacy and survival rates, 15%-30% of patients relapse and/or die. We aimed to identify molecular profiles and microenvironment makeup in leukemic bone marrow samples...
Autores principales: | Abbate, Mercedes, Ruiz, María Sol, Avendaño, Daniel, Riccheri, María Cecilia, Vazquez, Elba, Cotignola, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906527/ http://dx.doi.org/10.1200/GO.22.23000 |
Ejemplares similares
-
Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse
por: Leonardi, Daiana B., et al.
Publicado: (2016) -
Long Non-Coding RNAs (lncRNAs) Dysregulated in Tumor Progression to Castration-Resistant Prostate Cancer
por: Ledesma-Bazan, Sabrina, et al.
Publicado: (2022) -
Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1, HSPB1, DDB1 and 14-3-3ζ/δ Interaction
por: Lage-Vickers, Sofia, et al.
Publicado: (2022) -
Tissue Proteomics and Custom-Made Transcriptomics Analysis Tool Revel PPP1R12B, FBLN5, CRIP2, and POSTN as Potential Prognostic Biomarkers in Prostate Cancer
por: Bizzotto, Juan, et al.
Publicado: (2022) -
Modulation of Metastasis and Stemness-Associated Genes by Heme Oxygenase 1 (HO-1) in Prostate Cancer
por: Sabater, Agustina, et al.
Publicado: (2022)